Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Nickel, M; Moleda, D; Loew, T; Rother, W; Pedrosa Gil, F.
Cabergoline treatment in men with psychogenic erectile dysfunction: a randomized, double-blind, placebo-controlled study.
Int J Impot Res. 2006; 19(1):104-107
Doi: 10.1038/sj.ijir.3901483
Web of Science
PubMed
FullText
FullText_MUG
- Leading authors Med Uni Graz
- Nickel-Palczynski Marius
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- The effectiveness of cabergoline in 50 men with psychogenic erectile dysfunction was investigated in a 4-month, randomized, placebo-controlled, double-blind study with validated psychological tests, and prolactin, follicle-stimulating hormone, luteinizing hormone and testosterone serum levels. Cabergoline treatment was well-tolerated and resulted in normalization of hormone levels in most cases. In the cabergoline-treated group, significant interactions between prolactin and testosterone serum concentrations were observed. Erectile function improved significantly. Sexual desire, orgasmic function, and the patient's and his partner's sexual satisfaction were also enhanced. Cabergoline may be an effective and safe alternative agent for men with psychogenic ED.
- Find related publications in this database (using NLM MeSH Indexing)
- Adult -
- Dopamine Agonists - therapeutic use
- Double-Blind Method -
- Erectile Dysfunction - blood Erectile Dysfunction - drug therapy Erectile Dysfunction - psychology
- Ergolines - therapeutic use
- Follicle Stimulating Hormone - blood
- Humans -
- Libido -
- Luteinizing Hormone - blood
- Male -
- Middle Aged -
- Orgasm -
- Patient Satisfaction -
- Placebos -
- Prolactin - blood
- Testosterone - blood
- Find related publications in this database (Keywords)
- psychogenic erectile dysfunction
- libido
- cabergoline
- prolactin
- testosterone
- quality of life